NICE consultations

Endometriosis Quality standard consultation 

The consultation is open until 16 March, the comments form can be downloaded from NICE

The briefing paper includes a brief description of the topic, a summary of each of the
suggested quality improvement areas and supporting information it can be accessed here 

Acute coronary syndromes:Draft scope consultation 

This guidance will partially update the following:

  • (CG94)
  • (CG172)
  • (CG167)
  • (CG130)

The consultation closes 19 March 2018, details and project documents from NICE

Unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor: Interventional procedure consultation: 2

The consultation closes 22 March 2018

The consultation documents are available from NICE

Intranasal phototherapy for allergic rhinitis: Interventional procedure consultation

The consultation closes 22 March 2018

The consultation documents are available from NICE

Laparoscopic ventral mesh rectopexy for internal rectal prolapse

The consultation closes 22 March 2018

Interventional procedure consultation document  can be accessed here 

NICE Shared learning database

There are three new examples of good practice on NICE Shared Learning: workplace-1245776_1920

Planning medicines support

The Social Care Institute for Excellence in partnership with NICE has published Discussing and planning medicines support: a quick guide for home care managers providing medicines support. This guide will be helpful to managers of services where it has been agreed that medicines support will be included as part of the home care service. It covers: discussing medicines support; The 6 rights of medicines administration; planning and reviewing medicines support and medicines policy.

NICE approves breakthrough breast cancer drugs

NICE confirms that it will recommend that breakthrough cancer drugs palbociclib and ribociclib be provided on the NHS for women with advanced breast cancer| story via OnMedica

There are around 45,000 new diagnosis of breast cancer each year in England and it is estimated that around 8,000 of these people would be eligible for treatment with either palbociclib or ribociclib.


In draft guidance, NICE said breast cancer patients should have routine access to these two life extending drugs after a new deal with their manufacturing companies who agreed to lower the price and who gave more evidence for their effectiveness.

Palbociclib (Ibrance) from Pfizer and ribociclib (Kisqali) from Norvatis, are recommended for people with hormone receptor (HR) positive, HER2 negative locally advanced or secondary breast cancer.

NICE said that although there were some uncertainties on how long they extend the life expectancy of people with this type of breast cancer, these promising new drugs were found to stall the growth of cancer for an extra 10 months on average.

Smoking cessation in secondary care: acute and maternity settings

Self-assessment framework for NHS acute trusts to develop local action to reduce smoking prevalence and the use of tobacco. | Public Health England

This self-assessment tool breaks down the NICE guidance into 4 areas:


  • systems required to implement the guidance
  • communication required
  • training that will help staff to successfully implement the recommendations
  • treatments that should be available to support staff and service users

This self-assessment tool supports all of the recommendations applicable to acute services in the NICE guidelines on Smoking cessation in secondary care.

Public Health England has also developed a suite of resources including a self-assessment tool to support the implementation of NICE guidance in mental health settings.

NICE takes key role in new European project for faster access to Alzheimer’s disease drugs

Patients’ priorities will be brought to the fore in new Alzheimer’s project | NICE


NICE is taking part in a European project to speed up the development of new drugs to treat Alzheimer’s disease.

The ROADMAP initiative aims to establish a sustainable platform for real world evidence generation on Alzheimer’s disease.

The new project provides a unique and game-changing opportunity to gather evidence from other sources, such as electronic health records, and discover what outcomes are important to patients and carers.

Alzheimer’s disease, and the different ways it presents and progresses in different people, poses a difficulty for traditional clinical trials which do not always provide answers decision makers such as NICE would be looking for when assessing new drugs to treat the disease.

Read the full news story here

NICE: Traditional under the tongue temperature-taking helps patients avoid hypothermia during surgery

Traditional under the tongue or armpit temperature-taking are among the recommended ways of monitoring a patient’s temperature to help avoid hypothermia during surgery, says NICE.


The updated guideline on preventing and managing hypothermia during surgery also says that some familiar methods of taking a patient’s temperature – such as infrared ear thermometers and forehead strips – should not be used to measure the temperature in adults before, during or after surgery.

Hypothermia is classed as the body temperature dropping below 36.0°C – if this happens during surgery it can lead to the patient losing more blood, more chance of heart problems, and slower healing.  Normal body temperature is typically in a range between 36.5ºC and 37.5ºC.

Read the full overview here